Document Format Files
Seq | Description | Document | Type | Size |
---|---|---|---|---|
1 | ANNUAL REPORT | ea0241513-20f_nlspharma.htm iXBRL | 20-F | 2589143 |
2 | DESCRIPTION OF SECURITIES | ea024151301ex2-1_nlspharma.htm | EX-2.1 | 117142 |
3 | AGREEMENT OF MERGER AND PLAN OF REORGANIZATION | ea024151301ex4-28_nlspharma.htm | EX-4.28 | 18859 |
4 | LISTING OF SUBSIDIARIES | ea024151301ex8-1_nlspharma.htm | EX-8.1 | 1961 |
5 | INSIDER TRADING POLICY | ea024151301ex11b_nlspharma.htm | EX-11.B | 63821 |
6 | CERTIFICATION | ea024151301ex12-1_nlspharma.htm | EX-12.1 | 11620 |
7 | CERTIFICATION | ea024151301ex12-2_nlspharma.htm | EX-12.2 | 11715 |
8 | CERTIFICATION | ea024151301ex13-1_nlspharma.htm | EX-13.1 | 3947 |
9 | CERTIFICATION | ea024151301ex13-2_nlspharma.htm | EX-13.2 | 3963 |
10 | CONSENT OF PRICEWATERHOUSECOOPERS AG | ea024151301ex15-1_nlspharma.htm | EX-15.1 | 1960 |
11 | CONSENT OF MARCUM LLP | ea024151301ex15-2_nlspharma.htm | EX-15.2 | 2046 |
12 | GRAPHIC | image_001.jpg | GRAPHIC | 23049 |
13 | GRAPHIC | image_002.jpg | GRAPHIC | 36310 |
14 | GRAPHIC | image_003.jpg | GRAPHIC | 36310 |
15 | GRAPHIC | image_004.jpg | GRAPHIC | 19272 |
16 | GRAPHIC | image_005.jpg | GRAPHIC | 19152 |
17 | GRAPHIC | image_006.jpg | GRAPHIC | 28655 |
18 | GRAPHIC | image_007.jpg | GRAPHIC | 32696 |
19 | GRAPHIC | image_008.jpg | GRAPHIC | 34377 |
20 | GRAPHIC | image_009.jpg | GRAPHIC | 57810 |
21 | GRAPHIC | image_010.jpg | GRAPHIC | 24003 |
22 | GRAPHIC | image_011.jpg | GRAPHIC | 28233 |
23 | GRAPHIC | image_012.jpg | GRAPHIC | 22583 |
24 | GRAPHIC | image_013.jpg | GRAPHIC | 11268 |
25 | GRAPHIC | image_014.jpg | GRAPHIC | 18471 |
26 | GRAPHIC | image_015.jpg | GRAPHIC | 13747 |
27 | GRAPHIC | image_016.jpg | GRAPHIC | 18596 |
28 | GRAPHIC | image_017.jpg | GRAPHIC | 50851 |
29 | GRAPHIC | image_018.jpg | GRAPHIC | 35860 |
30 | GRAPHIC | image_019.jpg | GRAPHIC | 20789 |
31 | GRAPHIC | image_020.jpg | GRAPHIC | 16083 |
32 | GRAPHIC | image_021.jpg | GRAPHIC | 22106 |
33 | GRAPHIC | image_022.jpg | GRAPHIC | 13545 |
34 | GRAPHIC | image_023.jpg | GRAPHIC | 14087 |
35 | GRAPHIC | image_024.jpg | GRAPHIC | 17009 |
36 | GRAPHIC | image_025.jpg | GRAPHIC | 20495 |
37 | GRAPHIC | image_026.jpg | GRAPHIC | 27807 |
38 | GRAPHIC | image_027.jpg | GRAPHIC | 15297 |
39 | GRAPHIC | image_028.jpg | GRAPHIC | 18159 |
40 | GRAPHIC | image_029.jpg | GRAPHIC | 15729 |
41 | GRAPHIC | image_030.jpg | GRAPHIC | 17800 |
42 | GRAPHIC | image_031.jpg | GRAPHIC | 22008 |
43 | GRAPHIC | image_032.jpg | GRAPHIC | 22555 |
44 | GRAPHIC | image_033.jpg | GRAPHIC | 20178 |
Complete submission text file | 0001213900-25-044868.txt | 10438460 |
Data Files
Seq | Description | Document | Type | Size |
---|---|---|---|---|
45 | XBRL SCHEMA FILE | nlsp-20241231.xsd | EX-101.SCH | 56195 |
46 | XBRL CALCULATION FILE | nlsp-20241231_cal.xml | EX-101.CAL | 47573 |
47 | XBRL DEFINITION FILE | nlsp-20241231_def.xml | EX-101.DEF | 301942 |
48 | XBRL LABEL FILE | nlsp-20241231_lab.xml | EX-101.LAB | 556049 |
49 | XBRL PRESENTATION FILE | nlsp-20241231_pre.xml | EX-101.PRE | 318860 |
116 | EXTRACTED XBRL INSTANCE DOCUMENT | ea0241513-20f_nlspharma_htm.xml | XML | 605350 |
EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-39957 | Film No.: 25958903
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)